Aesthetic firms are betting that a growing pool of patients experiencing loose skin and facial volume loss from GLP-1 obesity ...

As many of us know, keeping weight in check can be hard. National numbers certainly reflect this. Rates of overweight and ...

About 1 in 8 Americans have used GLP-1s for weight loss — but more than three-quarters quit taking them within two years.

By Christy Santhosh May 1 (Reuters) - Eli Lilly's newly launched oral weight-loss drug, Foundayo, was prescribed 5,612 times ...

Experts have discovered a surprising new health benefit of weight-loss medication – among people who haven’t even taken it.

Simple ‘metabolic reset’ found to prevent weight rebound after discontinuing GLP-1 drugs - Minimally invasive endoscopic ...

The Hershey Company says its gum and mint sales are increasing, with demand potentially linked to reports of "Ozempic breath" ...

The majority of weight loss from GLP-1 medication is from fat loss, and not muscle loss, new evidence suggests.

Americans starting weight-loss medicines for the first time want lower cost and greater convenience as they consider pills from Novo Nordisk NOVOb.CO or Eli Lilly LLY.N, according to seven doctors who ...

Boehringer Ingelheim’s glucagon/GLP-1 dual agonist has driven 16.6% weight loss at Week 76 of a phase 3 study. While the ...

In pilot trial, duodenal mucosal resurfacing shows signal of benefit ...

Experts warn popular GLP‑1 drugs may pose added risks for some patients, highlighting the need for medical supervision.